<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: In 1997, the American <z:mp ids='MP_0002055'>Diabetes</z:mp> Association proposed two subcategories for type 1 <z:mp ids='MP_0002055'>diabetes</z:mp>: type 1A or immunomediated <z:mp ids='MP_0002055'>diabetes</z:mp> and type 1B or idiopathic <z:mp ids='MP_0002055'>diabetes</z:mp> characterized by negative beta-cell <z:hpo ids='HP_0002960'>autoimmunity</z:hpo> markers, lack of association with HLA, and fluctuating insulinopenia </plain></SENT>
<SENT sid="1" pm="."><plain>The aim of this study was to examine clinical characteristics, beta-cell function, HLA typing, and mutations in <z:hpo ids='HP_0004904'>maturity-onset diabetes of the young</z:hpo> (MODY) genes in patients with atypical type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> (type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> diagnosed at <z:hpo ids='HP_0003674'>onset</z:hpo>, without pancreatic autoantibodies and fluctuating insulinopenia) </plain></SENT>
<SENT sid="2" pm="."><plain>RESEARCH DESIGN AND METHODS: Eight patients with atypical type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> (<z:hpo ids='HP_0000001'>all</z:hpo> men, 30.7 +/- 7.6 years) and 16 newly diagnosed age- and sex-matched patients with type 1A <z:mp ids='MP_0002055'>diabetes</z:mp> were studied retrospectively </plain></SENT>
<SENT sid="3" pm="."><plain>Islet cell, GAD, tyrosine phosphatase and insulin antibodies, and basal and stimulated plasma C-<z:chebi fb="7" ids="16670">peptide</z:chebi> were measured at <z:hpo ids='HP_0003674'>onset</z:hpo> and after 1 year </plain></SENT>
<SENT sid="4" pm="."><plain>HLA-DRB1-DQA1-DQB1 typing and screening for mutations in the HNF-1alpha and HNF-4alpha genes were performed from genomic DNA </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Atypical patients displayed significantly higher BMI and better beta-cell function at <z:hpo ids='HP_0003674'>onset</z:hpo> and after 12 months </plain></SENT>
<SENT sid="6" pm="."><plain>Three patients carried protective or neutral type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> haplotypes, five patients displayed heterozygosity for susceptible and protective haplotypes, and seven patients showed Asp(beta57) </plain></SENT>
<SENT sid="7" pm="."><plain>We found a nondescribed variant Pro436Ser in exon 10 of the HNF-4alpha gene in one atypical patient without susceptible haplotypes </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: In our population, there are atypical forms of <z:hpo ids='HP_0011462'>young adult-onset</z:hpo> <z:hpo ids='HP_0001946'>ketosis</z:hpo>-prone <z:mp ids='MP_0002055'>diabetes</z:mp> initially diagnosed as type 1 <z:mp ids='MP_0002055'>diabetes</z:mp>, differing from type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> in the absence of beta-cell <z:hpo ids='HP_0002960'>autoimmunity</z:hpo>, persistent beta-cell function capacity, fluctuating insulin requirements and <z:hpo ids='HP_0001946'>ketosis</z:hpo>-prone episodes, as well as clinical features of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="9" pm="."><plain>Only one subgroup could be strictly classified as having type 1B <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="10" pm="."><plain>Additional information is still needed to improve our understanding of the mechanisms that finally lead to the disease </plain></SENT>
</text></document>